Screener
Medtronic MDT Diabetes — Selling, general, and administrative expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
| (in millions) | Cardiovascular | Neuroscience | Medical Surgical | Diabetes | Total |
|---|---|---|---|---|---|
| Less: | |||||
| Cost of products sold, excluding amortization of intangible assets | 1,159 | 815 | 867 | 332 | 3,173 |
| Research and development expense | 284 | 153 | 174 | 109 | 720 |
| Selling, general, and administrative expense | 1,129 | 841 | 628 | 300 | 2,897 |
| Other segment items(2) | (14) | 12 | 6 | (2) | 3 |
| Reportable segment operating profit | $899 | $737 | $499 | $57 | $2,192 |
| Reconciliation of segment profit / (loss) | |||||
| Other operating segment profit (loss)(1) | (1) |
Item 1. Financial Statements
FAQ
- What is Medtronic's diabetes — selling, general, and administrative expense?
- Medtronic (MDT) reported diabetes — selling, general, and administrative expense of $300M in Q4 2025.
- How has Medtronic's diabetes — selling, general, and administrative expense changed year-over-year?
- Medtronic's diabetes — selling, general, and administrative expense increased by 12.8% year-over-year, from $266M to $300M.
- What is the long-term trend for Medtronic's diabetes — selling, general, and administrative expense?
- Over 2 years (2023 to 2025), Medtronic's diabetes — selling, general, and administrative expense has grown at a 6.0% compound annual growth rate (CAGR), from $705M to $792M.
- What does diabetes — selling, general, and administrative expense mean?
- This includes the costs of sales force compensation, marketing, legal, and administrative support functions dedicated to the diabetes business. It reflects the overhead required to sell and support medical devices in the global healthcare market. Managing these expenses is critical to maintaining healthy operating margins in a competitive landscape.
Ask your AI about Medtronic's diabetes — selling, general, and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude